Octapharma Revenue and Competitors

Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. As a family-owned company, Octapharma believes in investing to make a difference in people’s lives and has been doing so since 1983; because it’s in our blood.\n\nAt Octapharma, our passion drives us to provide new health solutions advancing human life. This is our vision. We thrive as an organisation in which people take ownership, have integrity, demonstrate grounded and confident leadership, drive sustainability, and are inspired by and eager to embrace entrepreneurship.\n\nWe employ more than 9,300 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas:\n\nHaematology (coagulation disorders)\nImmunotherapy (immune disorders)\nCritical care (bleeding management and functional volume replacement)\n\nOctapharma has seven R&D sites and six state-of-the-art manufacturing facilities in Austria, France, Germany, Mexico and Sweden, in addition to more than 120 plasma centres across Europe and the US. \n\nFor more information visit: www.octapharma.com